Mitchell Kaye

The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease

Stephen I. Rennard, Charles Fogarty, Steven G. Kelsen et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 426 citations

Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON

Bruno Crestani, John T. Huggins, Mitchell Kaye et al. · The Lancet Respiratory Medicine · 2018 · 235 citations

Antifibrotic Therapy, Open-label Extension Study, Idiopathic Pulmonary Fibrosis +5

The Effect of Cellulose Overproduction on Binding and Biofilm Formation on Roots by <i>Agrobacterium tumefaciens</i>

Ann G. Matthysse, Mazz Marry, Leonard Krall et al. · Molecular Plant-Microbe Interactions · 2005 · 105 citations · Full text

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

Toby M. Maher, Susanne Stowasser, Yasuhiko Nishioka et al. · The Lancet Respiratory Medicine · 2019 · 96 citations · Full text

Fibrosis, Extracellular Matrix Turnover, Inflammatory Lung Disease +7

Feasibility and Value of Video-Assisted Thoracoscopic Surgery Wedge Excision of Small Pulmonary Nodules in Patients with Malignancy

J Burdine, Lyle D. Joyce, Michael B. Plunkett et al. · CHEST Journal · 2002 · 76 citations

Small Pulmonary Nodules, Surgical Oncology, Minimally Invasive Procedure +7